Dexcel Pharma Competitors and Similar CompaniesClear all

Dexcel Pharma's competitors and similar companies include UCB, Cipla, Mankind Pharma and EMS Pharma.

	Dexcel Pharma Dexcel Pharma is a specialty pharmaceutical company that focuses on the development, manufacturing, and marketing of prescription, generics, and over-the-counter pharmaceutical products.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.	EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
Founding Date	Founding Date 1968	Founding Date 1928	Founding Date 1935	Founding Date 1995	Founding Date 1964
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations אור עקיבא, IL HQ Alzenau, DE Jerusalem, IL Daventry, GB	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations New Delhi, IN HQ	Locations BR HQ
Employees	Employees 515	Employees 9,052	Employees 27,764	Employees 16,2532% increase	Employees 12,7441% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods €1.4b (FY, 2025)	Cost of goods ₹95.5b (FY, 2026)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit €7.2b (FY, 2025)	Gross profit ₹195b (FY, 2026)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income €1.6b (FY, 2025)	Net income ₹38.7b (FY, 2026)	Net income N/A	Net income N/A